(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol CAS 127852-28-2 Purity >99.0% (GC) Aprepitant Intermediate

Short Description:

(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

CAS: 127852-28-2

Purity: >99.0% (GC)

Appearance: White to Off-White Powder

Intermediate of Aprepitant (CAS: 170729-80-3)

High Quality, Commercial Production

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Leading manufacturer and supplier
Intermediates of Aprepitant (CAS: 170729-80-3)
4-Benzyl-2-Hydroxymorpholin-3-one CAS 287930-73-8
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol CAS 127852-28-2
Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
Synonyms	(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl Alcohol; (R)-3,5-Bis(trifluoromethyl)-α-Methylbenzyl Alcohol
CAS Number	127852-28-2
CAT Number	RF-CC302
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C10H8F6O
Molecular Weight	258.16
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Powder
Purity / Analysis Method	>99.0% (GC)
Melting Point	53.0~57.0℃
Optical Rotation	+26.0° ~ +29.0° (C=1 IN Acetonitrile)
Infrared Spectrum	Conforms to Structure
Test Standard	Enterprise Standard
Usage	Intermediate of Aprepitant (CAS: 170729-80-3)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol (CAS: 127852-28-2) is used as pharmaceutical intermediate, chiral synthesis for organic reactions, Aprepitant (CAS: 170729-80-3) intermediate. Aprepitant is an antiemetic chemical compound. Aprepitant is used for the prevention of acute and delayed chemotherapy-induced nausea and vomiting(CINV) and for prevention of postoperative nausea and vomiting. It was first successfully developed by Merck Company (German). In March 2003, the US Food and Drug Administration approved it for being used in the treatment of chemotherapy vomiting.